Dermatomyositis-like rash associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody necrotizing myopathy following COVID-19 infection and vaccination

Authors

  • Timothy Fullam, MD Brooke Army Medical Center
  • Swathy Chandrashekhar, MD
  • Constantine Farmakidis, MD
  • Omar Jawdat, MD
  • Mamatha Pasnoor, MD
  • Mazen M. Dimachkie, MD
  • Erik Ensrud, MD

DOI:

https://doi.org/10.17161/rrnmf.v2i5.15812

Keywords:

Myositis, COVID-19, dermatomyositis, necrotizing myopathy, muscle pathology

Downloads

Download data is not yet available.

References

References

Pasnoor M, Barohn RJ, Dimachkie MM. Toxic myopathies. Curr Opin Neurol 2018;31:575-82.

Lim D, Landon-Cardinal O, Ellezam B, et al. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report. SAGE Open Med Case Rep 2020;8:2050313X20984120.

McGrath ER, Doughty CT, Amato AA. Autoimmune Myopathies: Updates on Evaluation and Treatment. Neurotherapeutics 2018;15:976-94.

Lavian M, Mozaffar T, Goyal N. Clinical Dermatomyositis Associated with Anti-HMG-CoA Reductase Antibody Positive Immune Mediated Necrotizing Myopathy: A Case Report (P2.125). Neurology 2017;88:P2.125.

Merlant M, Fite C, Kottler D, et al. Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies. Ann Dermatol Venereol 2019;146:550-

Parikh P, Tavee J, Soltanzadeh P, Mammen A, McKeever P, Li Y. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Muscle Nerve 2018;57:E135-E6.

Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010;62:2757-66.

Tiniakou E, Christopher-Stine L. Immune-mediated necrotizing myopathy associated with statins: history and recent developments. Curr Opin Rheumatol 2017;29:604-11.

Mammen AL, Pak K, Williams EK, et al. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 2012;64:269-72.

Musset L, Allenbach Y, Benveniste O, et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmun Rev 2016;15:983-93.

Hudson M, Luck Y, Stephenson M, et al. Anti-HMGCR antibodies in systemic sclerosis. Medicine (Baltimore) 2016;95:e5280.

Alshehri A, Choksi R, Bucelli R, Pestronk A. Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm 2015;2:e124.

Hou Y, Shao K, Yan Y, et al. Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy. J Neurol 2021.

Jiao Y, Cai S, Lin J, et al. Statin-naive anti-HMGCR antibody-mediated necrotizing myopathy in China. J Clin Neurosci 2018;57:13-9.

Kadoya M, Hida A, Hashimoto Maeda M, et al. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm 2016;3:e290.

Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Group EtWS. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018. Neuromuscul Disord 2020;30:70-92.

Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20.

Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-90.

Veyseh M, Koyoda S, Ayesha B. COVID-19 IgG-related autoimmune inflammatory necrotizing myositis. BMJ Case Rep 2021;14.

Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2021;177:51-64.

Mantilla, EC, Pasnoor M, Dimachkie MM. Rhabdomyolysis and COVID-19 Infection: Is It Due to Statin Use or Anti-TIF-1-y Antibodies? RRNMJ Neuromuscular Journal 2020; 1(3): 22-25. DOI https://doi.org/10.17161/rrnmf.v1i3.13719

Khan NAJ, Khalid S, Ullah S, Malik MU, Makhoul S. Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies. J Investig Med High Impact Case Rep 2017;5:2324709617709031.

Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM 2021.

Downloads

Published

2021-12-20

How to Cite

Timothy Fullam, Chandrashekhar, S., Farmakidis, C., Jawdat, O., Pasnoor, M. ., Dimachkie, M. M., & Ensrud, E. (2021). Dermatomyositis-like rash associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody necrotizing myopathy following COVID-19 infection and vaccination. RRNMF Neuromuscular Journal, 2(5), 58–61. https://doi.org/10.17161/rrnmf.v2i5.15812

Issue

Section

Clinic Stuff (Case Reports)